Galsulfase (Naglazyme) [Internet].

The objective of this review is to evaluate the beneficial and harmful effects of galsulfase 1 mg/kg IV infusion once weekly as long-term enzyme replacement therapy (ERT) in patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) (MPS VI).

http://ift.tt/2kjpLL0